{
  "subset": "indication",
  "disease": "Non-CF bronchiectasis",
  "relation": "indication",
  "gold_drugs": [
    "azli",
    "brensocatib",
    "ciprofloxacin dpi"
  ],
  "seeds_initial": [
    "Bronchodilators",
    "Antibiotics",
    "Mucolytics",
    "Corticosteroids",
    "Hypertonic saline",
    "Azithromycin",
    "Dornase alfa",
    "Ipratropium",
    "Salbutamol",
    "Tobramycin",
    "Levofloxacin",
    "Ambroxol"
  ],
  "seed_history": [
    [
      "Bronchodilators",
      "Antibiotics",
      "Mucolytics",
      "Corticosteroids",
      "Hypertonic saline",
      "Azithromycin",
      "Dornase alfa",
      "Ipratropium",
      "Salbutamol",
      "Tobramycin",
      "Levofloxacin",
      "Ambroxol"
    ]
  ],
  "final_report": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_bronchodilators",
          "name": "Bronchodilators"
        },
        "score": 0.76,
        "graph_snapshot_ref": "GE_H1_round2",
        "key_assumptions": [
          "Bronchodilators 通过气道放松改善呼吸功能",
          "支持 Non-CF Bronchiectasis 的治疗适应症"
        ],
        "caveats": [
          "尽管机制已建立，但对部分耐受性和长期效果的验证仍需关注"
        ],
        "confidence": "high"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Bronchodilators → Airway Relaxation → Respiratory Function Improvement → Symptom Relief",
          "reason": "形成了完整的药理作用链，指向可治疗 Non-CF Bronchiectasis"
        }
      ],
      "remaining_gaps": [
        "部分药物（如抗生素和粘液溶解剂）的适应症证据不足"
      ]
    },
    "seed_retrospective": {
      "batches": [],
      "lessons": []
    },
    "prompt_patches": [],
    "heuristics": []
  },
  "experience_used": true,
  "explorer_prompt": "List drugs that could be indicated for the rare disease 'Non-CF bronchiectasis'. Return only names.\n\n# Prior guidance for Explorer:\n- 维持现有假设的多样性，确保机制与疗效的覆盖\n\n# Heuristics:\n- When Non-CF bronchiectasis: then 优先考虑改善呼吸功能的药物，同时评估其副作用"
}